Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Levonorgestrel Non-Micronized Recalled by Qinhuangdao Zizhu Pharmaceutical, Co. Due to cGMP Deviations; lack of quality assurance.
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Qinhuangdao Zizhu Pharmaceutical, Co. directly.
Affected Products
Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-012-01),
Quantity: N/A
Why Was This Recalled?
cGMP Deviations; lack of quality assurance.
Where Was This Sold?
This product was distributed to 6 states: CO, MN, NJ, NY, SC, TX
About Qinhuangdao Zizhu Pharmaceutical, Co.
Qinhuangdao Zizhu Pharmaceutical, Co. has 7 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report